Treatment of primary Sjögren syndrome with rituximab. In response

Ann Intern Med. 2014 Sep 2;161(5):377-8. doi: 10.7326/L14-5017-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use*
  • Male
  • Sjogren's Syndrome / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors